- Certificate dated 30.09.2018
- Certificate dated 31.03.2018
- Certificate dated 31.03.2019
- Certificate dated 30.09.2019
- Certificate dated 31.03.2020
- Certificate dated 30.09.2020
- Certificate dated 31.03.2021
- Certificate dated 31.03.2022 40(9)
- Certificate dated 31.03.2023 40(9)
- Certificate dated 31.03.2024 40(9)
- Code of Conduct
- Policy for determining Material Subsidiaries
- Policy on Archival of Documents
- Whistle Blower Policy/ Vigil Mechanism
- Criteria for Determining Materiality of Events
- Policy on Preservation of Documents
- Policy on Related Party Transaction
- Policy on Remuneration Nomination and Boar Diversity
- CSR POLICY
- Beta-Investor Grievance Redressal Policy
- T&C of ID'S Appointment
- Code of Business conduct for Directors & Senior Management
- Director Familiarization Program
- Certificate dated 31.03.2018
- Certificate dated 30.09.2018
- Certificate dated 31.03.2019
- Certificate dated 30.09.2019
- Certificate dated 31.03.2020
- Certificate dated 30.09.2020
- Certificate dated 31.03.2021
- Certificate dated 31.03.2022 7(3)
- Certificate dated 31.03.2023 7(3)
- Certificate dated 31.03.2024 7(3)
- Financial Result Dated 31.03.2018
- Financial Result Dated 30.09.2018
- Financial Result Dated 31.03.2019
- Financial Result Dated 30.09.2019
- Financial Result Dated 31.03.2020
- Financial Result Dated 30.09.2020
- Financial Result Dated 31.03.2021
- Financial Results dated 30.09.2021
- Financial results dated 31.03.2022
- Financial Results Dated 30.09.2022
- Financial Results Dated 31.03.2023
- Financial Results Dated 30.09.2023
- Financial Results Dated 31.03.2024
- Financial Results Dated 30.09.2024
- Financial Results Dated 31.03.2025
- Financial Results Dated 30.09.2025
- Intimation of Concall dated 17.05.2018
- Intimation of Concall dated 06.05.2021
- Intimation of Concall dated 07.12.2021
- Intimation of concall dated 28.04.2022
- Intimation of concall dated 28.10.2022
- Intimation of concall dated 19.05.2023
- Intimation of concall dated 08.11.2023
- Intimation of concall dated 15.05.2024
- Intimation of concall dated 07.11.2024
- Intimation of concall dated 16.5.2025
- Intimation of concall dated 07.11.2025
- Intimation Dated 09.01.2018
- Intimation Dated 07.03.2018
- Intimation Dated 14.06.2018
- Intimation Dated 06.12.2018
- Intimation Dated 29.12.2018
- Intimation Dated 24.01.2019
- Intimation Dated 24.04.2019
- Intimation of Investor Meet dated 10.12.2025
- Intimation of cancellation of Investor Meet dated 10.12.2025
- Intimation of Investor Meet dated 18.12.2025
- Notice dated 04.02.2019
- Notice dated 01.03.2019
- Notice dated 23.03.2019
- Notice dated 28.03.2019
- Notice dated 01.05.2019
- Notice dated 13.05.2019
- Notice dated 29.05.2019
- Notice dated 01.07.2019
- Notice dated 01.08.2019
- Notice dated 31.08.2019
- Notice dated 27.09.2019
- Notice dated 23.10.2019
- Notice dated 08.11.2019
- Notice dated 22.11.2019
- Pattern dated 11.10.2017
- Pattern dated 31.03.2018
- Pattern dated 30.09.2018
- Pattern dated 31.03.2019
- Pattern dated 01.05.2019
- Pattern dated 30.09.2019
- Pattern dated 31.03.2020
- Pattern dated 30.06.2020
- Pattern dated 30.09.2020
- Pattern dated 31.12.2020
- Pattern dated 31.03.2020
- Pattern dated 30.06.2021
- Pattern dated 30.09.2021
- Pattern dated 31.12.2021
- Pattern Dated 31.03.2022
- Pattern dated 30.06.2022
- Pattern dated 30.09.2022
- Pattern dated 31.12.2022
- Pattern dated 31.03.2023
- Pattern Dated 30.06.2023
- Pattern dated 30.09.2023
- Pattern dated 31.12.2023
- Pattern dated 31.03.2024
- Pattern dated 30.06.2024
- Pattern dated 30.09.2024
- Pattern dated 31.12.2024
- Pattern dated 27.03.2025
- Pattern dated 31.03.2025
- Pattern dated 30.06.2025
- Pattern dated 30.09.2025
- Pattern dated 31.12.2025
- Dated 28.05.2020
- Dated 17.06.2020
- Dated 06.07.2020
- Dated 31.08.2020
- Dated 24.09.2020
- Dated 19.10.2020
- Dated 27.01.2021
- Dated 05.03.2021
- Dated 27.04.2021
- Dated 31.08.2021
- Dated 25.10.2021
- Dated 08.05.2023
- Dated 01.09.2023
- Dated 07.11.2023
- Dated 14.05.2024
- Dated 19.10.2024
- Dated 06.11.2024
- Dated 05.02.2025
- Dated 15.05.2025
- Dated 06.11.2025
- Dated 29.11.2025
- Dated 09.01.2026
- 15th AGM_Newspaper Clipping-English
- 15th AGM_Newspaper Clipping-Hindi
- 15th AGM_Transcript
- 15th AGM_Voting Results
- 16th AGM_Newspaper Clipping-English
- 16th AGM_Newspaper Clipping-Hindi
- Article of Association
- Memorandum of Association
- 16th AGM Transcript
- 16th AGM Voting Results
- 17th AGM_Newspaper Clipping-English
- 17th AGM_Newspaper Clipping-Hindi
- 17TH AGM VOTING RESULTS
- 18th AGM_Newspaper Clipping-Hindi
- 18th AGM_Newspaper Clipping-English
- 18TH AGM VOTING RESULTS
- 15th AGM PROCEEDINGS-30.09.2020
- 16th AGM PROCEEDINGS-30.09.2021
- 17th AGM PROCEEDINGS-29.09.2022
- 18th AGM PROCEEDINGS-30.09.2023
- 19th AGM_Newspaper Clipping-Hindi
- 19th AGM_Newspaper Clipping-English
- 19th AGM PROCEEDINGS-30.09.2024
- 20th AGM_Newspaper Clipping-English
- 20th AGM_Newspaper Clipping-Hindi
- 20th AGM PROCEEDINGS-30.09.2025
- 20 product reg certificates from Ministry of Health Uzbekistan 27.04.2020
- Acquisition of Adley Formulations 05.11.2018
- Adley lab Ltd received WHO GMP 19.07.2021
- Azer News Beta 20.10.2018
- International Plant Approvals 15.11.2019
- Intimation of Concall 17.05.2018
- Intimation of Incorporation of a Wholly Owned Subsidiary Company 11.10.2018
- Intimation of Investor Meet 24.04.2019
- Launch of Axitinib by Beta Drugs Limited 04.09.2020
- lmpact of COVID 19 pandemic on the business of the Company 23.06.2020
- New Product Launches 12.06.2020
- Update on Beta Uzbekistan Subsidiary 12.03.2019
- Update on Beta Uzbekistan Subsidiary 16.08.2019
- Update on Beta Drugs API plant ready to take big leap
- Update on Beta Drugs API plant ready to take big leap
- New product launch to drive growth for Beta Drugs.PDF
- Beta Drugs Ltd. bags yet another DCGI approval for its new drug_ KABONIB after MDS-O
- Beta Drugs gets the DCGI nod to launch Enzalutamide 160mg for the treatment of Prostate Cancer
- Beta Drugs Limited sets a new industry benchmark with a dedicated oral suspension plant of cancer medicines
- Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs Limited Earns Prestigious Spot on Forbes List of 200 Best Under a Billion
- Beta Drugs entered into a definitive agreement to acquire a 66.09% stake in Nivian Lifesciences Private Limited
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2019
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2020
- Financial Statement of Adley Lab Limited as on 31.03.2020
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2021
- Financial Statement of Adley Lab Ltd as on 31.03.2021
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2022
- Financial Statement of Adley Lab Limited as on 31.03.2022
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2023
- Financial Statement of Adley Lab Limited as on 31.03.2023
- Financial Statement of Beta Research Pvt Ltd as on 31.03.2023
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2024
- Financial Statement of Adley Lab Limited as on 31.03.2024
- Financial Statement of Beta Research Pvt Ltd as on 31.03.2024
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2025
- Financial Statement of Adley Lab Limited as on 31.03.2025
- Financial Statement of Beta Research Pvt Ltd as on 31.03.2025
- Financial Statements of Adley Formulations Private Limited as on 31.03.2025
- Statement Reg_ 32(1) _SEBI (LODR) 31.03.2018
- Statement Reg_ 32(1) _SEBI (LODR) 30.09.2018
- Statement Reg_32(1)_ SEBI (LODR) 31.03.2019
- Statement Reg_32(1)_SEBI (LODR) 30.09.2019
- Statement Reg_ 32(1) _SEBI (LODR) 31.03.2020
- Statement Reg_32(1)_SEBI (LODR) 31.03.2025
- Statement Reg_32(1)_SEBI (LODR) 30.09.2025
- EGM NOTICE DATED 12.11.2024
- PCS Certificate
- VALUATION REPORT
- Corrigendum to Notice of EGM
- Corrigendum 2
- Proceeding of EGM 12th November 2024
- EGM NOTICE DATED 04.02.2026
- VALUATION REPORT 08.01.2026
- PCS Certificate 09.01.2026
- ENGLISH NEWSPAPER ADVERTISEMENT FOR EGM DATED 04.02.2026
- HINDI NEWSPAPER ADVERTISEMENT FOR EGM DATED 04.02.2026
